Information  X 
Enter a valid email address

OMV Petrom S.A. (PETB)

  Print      Mail a friend

Wednesday 30 May, 2018

OMV Petrom S.A.

Changes in the Executive Board

RNS Number : 7161P
OMV Petrom S.A.
30 May 2018
 

Ad hoc report 

 

 

In compliance with Law no. 24/2017 on issuers of financial instruments and market operations and National Securities Commission Regulation no. 1/2006 on issuers and operations with securities

 

Date of report: May 30, 2018

Name of issuer: OMV Petrom S.A.

Headquarters: Bucharest, 22 Coralilor Street, District 1, ("Petrom City")

Telephone/fax number: +40 372 160697/ +40 372 868518

Sole registration number at the Trade Register Office: 1590082

Fiscal attribute: RO

Trade Register Number: J 40/8302/1997

Share capital: 5,664,410,833.5 RON

Regulated market on which the issued shares are traded: Bucharest Stock Exchange and London Stock Exchange

 

 

 

 

Significant event to be reported:

 

Changes in the Executive Board

 

 

Today, the Supervisory Board approved the effective date of July 1, 2018 for Franck Neel to take over the position as Member of the Executive Board of OMV Petrom responsible for Downstream Gas. Franck Neel's appointment to this position was already announced on April 26, 2018. The Supervisory Board also took note that Lacramioara Diaconu-Pintea's mandate as Member of the Executive Board of OMV Petrom will cease as of June 30, 2018, when Franck Neel takes over the position.

 

Further, Neil Anthony Morgan tendered his resignation as Executive Board Member of OMV Petrom responsible for Downstream Oil effective November 30, 2018.

 

 

 

Christina Verchere                                                                             Stefan Waldner

Chief Executive Officer                                                                         Chief Financial Officer               


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAXBLFXVEFBBBL

a d v e r t i s e m e n t